J&J unit and Gilead's combo HIV pill Complera gets FDA OK

08/10/2011 | Forbes

The FDA approved Complera, an oral HIV drug containing Truvada, from Gilead Sciences, and Edurant, from Johnson & Johnson unit Tibotec. Complera is indicated for once-daily use by previously untreated patients.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC